You have 9 free searches left this month | to do more

venetoclax

Venetoclax is a drug used to treat Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and other conditions. Venetoclax is being actively studied in 216 studies and prior, has been studied in 19.

Top SponsorsTop SitesTop Investigators
AbbVieM D Anderson Cancer CenterMatthew S. Davids, MD
M.D. Anderson Cancer CenterMD Anderson Cancer CenterPaolo Ghia
Hoffmann-La RocheDana Farber Cancer InstituteAndrew Lane
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
  • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • (no location specified)
2021-09-16
Sep 16, 2021
D
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
N
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2020-11-03
Nov 3, 2020
N
Recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2020-11-02
Nov 2, 2020
H
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Hannover, Niedersachsen, Germany
    Medical School Hannover
2021-02-15
Feb 15, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • BCR-ABL Negative
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-09-29
Sep 29, 2021
D
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
A
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Venetoclax
  • (no location specified)
2021-05-24
May 24, 2021
K
Suspended
  • Primary CNS Lymphoma
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
2021-09-15
Sep 15, 2021
D
Recruiting
  • Leukemia
  • Venetoclax
  • Standard Chemotherapy
  • Boston, Massachusetts
  • +1 more
2021-08-02
Aug 2, 2021
H
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Helsinki, Uusimaa, Finland
    HelsinkiUCH
2021-08-24
Aug 24, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
2021-02-19
Feb 19, 2021
D
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-03-15
Mar 15, 2021
D
Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-08-28
Aug 28, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
2021-05-12
May 12, 2021
C
Recruiting
  • Non-hodgkin Lymphoma
  • Venetoclax
  • Cleveland, Ohio
  • +1 more
2021-05-11
May 11, 2021
M
Not yet recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-07-27
Jul 27, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Edmonton, Alberta, Canada
  • +1 more
2021-05-14
May 14, 2021
D
Recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
2020-12-21
Dec 21, 2020
B
Not yet recruiting
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Loncastuximab tesirine
  • Venetoclax
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
2021-10-05
Oct 5, 2021
D
Recruiting
  • Richter Syndrome
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
  • +3 more
2021-06-21
Jun 21, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
2021-06-21
Jun 21, 2021
J
Recruiting
  • Acute Myeloid Leukemia (AML)
  • +4 more
  • Venetoclax
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-07-08
Jul 8, 2021
M
Recruiting
  • BTK Gene Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-29
Mar 29, 2021